iX Biopharma Ltd. (SGX:42C)
Singapore
· Delayed Price · Currency is SGD
0.182
-0.009 (-4.71%)
Mar 9, 2026, 5:04 PM SGT
iX Biopharma Ratios and Metrics
Market cap in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 189 | 14 | 22 | 70 | 122 | 167 | |
| Market Cap Growth | 871.14% | -36.24% | -68.05% | -43.05% | -26.84% | 3.17% | |
| Enterprise Value | 190 | 17 | 22 | 62 | 111 | 162 | |
| PS Ratio | 26.11 | 1.83 | 3.74 | 11.79 | 8.51 | 95.91 | |
| PB Ratio | 45.65 | 38.92 | 5.13 | 4.40 | 6.20 | 14.29 | |
| P/TBV Ratio | 48.68 | 149.55 | 5.51 | 4.48 | 6.31 | 14.81 | |
| P/FCF Ratio | - | - | - | - | 41.89 | - | |
| P/OCF Ratio | - | - | - | - | 39.21 | - | |
| EV/Sales Ratio | 26.24 | 2.20 | 3.73 | 10.51 | 7.70 | 92.74 | |
| EV/EBITDA Ratio | - | - | - | - | 96.40 | - | |
| EV/EBIT Ratio | - | - | - | - | 221.09 | - | |
| EV/FCF Ratio | -49.76 | - | - | - | 37.89 | - | |
| Debt / Equity Ratio | 1.63 | 16.17 | 1.20 | 0.27 | 0.22 | 0.36 | |
| Debt / EBITDA Ratio | - | - | - | - | 2.91 | - | |
| Debt / FCF Ratio | - | - | - | - | 1.51 | - | |
| Net Debt / Equity Ratio | 0.23 | 13.61 | 0.77 | -0.14 | -0.46 | -0.17 | |
| Net Debt / EBITDA Ratio | -0.18 | -0.85 | -0.47 | 0.24 | -7.99 | 0.18 | |
| Net Debt / FCF Ratio | -0.25 | -1.25 | -0.49 | 0.26 | -3.14 | 0.22 | |
| Asset Turnover | 0.50 | 0.60 | 0.30 | 0.22 | 0.61 | 0.10 | |
| Inventory Turnover | 5.46 | 4.98 | 4.21 | 3.86 | 2.09 | 2.14 | |
| Quick Ratio | 0.91 | 0.32 | 0.65 | 1.34 | 1.98 | 2.19 | |
| Current Ratio | 1.05 | 0.47 | 0.89 | 1.53 | 2.14 | 2.55 | |
| Return on Equity (ROE) | -155.52% | -431.07% | -106.91% | -54.02% | -29.23% | -75.27% | |
| Return on Assets (ROA) | -24.84% | -30.32% | -23.69% | -22.32% | 1.32% | -39.86% | |
| Return on Capital Employed (ROCE) | -72.70% | -272.70% | -103.50% | -53.80% | 2.40% | -75.20% | |
| Earnings Yield | -3.15% | -71.38% | -48.44% | -13.79% | -3.75% | -4.92% | |
| FCF Yield | -2.02% | -27.87% | -30.64% | -11.98% | 2.39% | -5.32% | |
| Buyback Yield / Dilution | -9.14% | -14.25% | -0.33% | -2.51% | -7.60% | -7.13% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.